Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-08-29

Clinical Trial Update: Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723) [Phase 3]

View source ↗

Summary

A Phase 3 completed trial comparing NOMAC-E2 combined oral contraceptive with a DRSP/EE-containing COC evaluating effects on ovarian function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DRSP/EE
  • NOMAC-E2 (nomegestrol acetate / 17β-estradiol)

Snippet

Sponsor: Organon and Co | Conditions: Contraception | Phase 3 | Status: COMPLETED | Results posted: 2011-08-29